Onconova Therapeutics Inc. (NASDAQ: ONTX) started the day on April 30, 2021, with a price decrease of -1.03% at $0.72. During the day, the stock rose to $0.7481 and sunk to $0.7005 before settling in for the price of $0.73 at the close. Taking a more long-term approach, ONTX posted a 52-week range of $0.19-$1.93.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -54.20%. Meanwhile, its Annual Earning per share during the time was 75.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 90.30%. This publicly-traded company’s shares outstanding now amounts to $236.61 million, simultaneously with a float of $221.88 million. The organization now has a market capitalization sitting at $171.88 million. At the time of writing, stock’s 50-day Moving Average stood at $0.9909, while the 200-day Moving Average is $0.6663.
While finding the extent of efficiency of the company that is accounted for 11 employees. It has generated 19,250 per worker during the last fiscal year. Meanwhile, its income per employee was -2,096,417. The stock had 3.42 Receivables turnover and 0.01 Total Asset turnover. For the Profitability, stocks operating margin was -10819.48 and Pretax Margin of -10888.74.
Onconova Therapeutics Inc. (ONTX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Onconova Therapeutics Inc.’s current insider ownership accounts for 0.30%, in contrast to 15.10% institutional ownership. According to the most recent insider trade that took place on Feb 16, this organization’s SVP Corp Dev & Gen Counsel bought 12,000 shares at the rate of 1.00, making the entire transaction reach 12,000 in total value, affecting insider ownership by 152,000. Preceding that transaction, on Feb 16, Company’s Chief Financial Officer bought 15,000 for 1.00, making the whole transaction’s value amount to 15,000. This particular insider is now the holder of 145,213 in total.
Onconova Therapeutics Inc. (ONTX) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2020, the organization reported -$0.03 earnings per share (EPS) for the three months, surpassing the consensus estimate (set at -$0.03) by $0. This company achieved a net margin of -10890.48 while generating a return on equity of -283.48. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
Onconova Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 90.30% and is forecasted to reach -0.12 in the upcoming year.
Onconova Therapeutics Inc. (NASDAQ: ONTX) Trading Performance Indicators
Let’s observe the current performance indicators for Onconova Therapeutics Inc. (ONTX). It’s Quick Ratio in the last reported quarter now stands at 2.00. The Stock has managed to achieve an average true range (ATR) of 0.08. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 859.41.
In the same vein, ONTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.14, a figure that is expected to reach -0.03 in the next quarter, and analysts are predicting that it will be -0.12 at the market close of one year from today.
Technical Analysis of Onconova Therapeutics Inc. (ONTX)
If we take a close look at the recent performances of Onconova Therapeutics Inc. (NASDAQ: ONTX), its last 5-days Average volume was 5.46 million that shows plunge from its year to date volume of 42.56 million. During the previous 9 days, stock’s Stochastic %D was recorded 68.34% While, its Average True Range was 0.0740.
Raw Stochastic average of Onconova Therapeutics Inc. (ONTX) in the period of the previous 100 days is set at 25.74%, which indicates a major fall in contrast to 61.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 112.29% that was lower than 163.87% volatility it exhibited in the past 100-days period.